Rekvina Laboratories Limited, a specialized pharmaceutical company focused on the manufacturing and marketing of therapeutic formulations, has announced the induction of Jay Chintan Patel into its Board of Directors. Appointed as an Additional Non-Executive Independent Director, Patel brings a fresh perspective to the company’s corporate governance framework. His appointment, effective in late January 2026, aligns with the company’s efforts to strengthen independent oversight as it navigates the competitive pharmaceutical landscape and evolving compliance requirements under the SEBI (LODR) Regulations.
Trending
- Pernod Ricard India Appoints Sonia Arora as Director of Consumer Insights
- PM Narendra Modi Becomes India’s Longest-Serving Head of Government
- Whole-time Director Indirakumar Resigns from Indrayani Biotech Board
- Secretary Debashree Mukherjee Assigned Additional Charge as Chairperson, NCVET
- Chief Growth Officer Amber Faulkner Joins Droga5 London
- Minister Laljit Singh Bhullar Resigns from Punjab Cabinet Following Official’s Suicide
- Sagarsoft (India) Appoints Finance Veteran Kanakadhara Srinivasan to its Board
- IAS Pramod Kumar Meherda Assigned Additional Charge as CEO, NRAA
